CD8A and adenoma: The levels of CD8+ TILs were significantly lower in the high-risk adenoma patients (n = 11, 2.3 (2.0)) than in the non-high-risk adenoma patients (n = 32, 4.3 (6.1); p = 0.015; Figure 5).